How Melanocortin Peptides Control Your Blood Pressure and Salt Response

Narrative review published in Current Opinion in Nephrology and Hypertension, synthesizing recent findings on the cardiovascular and renal effects of melanocortin peptides from both animal models and mechanistic studies.

Salt-sensitive hypertension affects a large proportion of people with high blood pressure, and insulin resistance frequently accompanies it — but the link between the two has been poorly understood. This review reveals melanocortin peptides as a missing piece of the puzzle, connecting salt handling, blood pressure, sympathetic nervous activity, and metabolic dysfunction through a single peptide system. It also raises an important safety consideration for melanocortin drugs: their potential cardiovascular effects.

This review connects melanocortin biology to cardiovascular medicine in unexpected ways. MC4R agonists (like setmelanotide for genetic obesity) are now FDA-approved drugs, and understanding their cardiovascular effects is critical for patient safety. The finding that melanocortins link salt sensitivity to insulin resistance could explain why hypertension and metabolic syndrome so often co-occur — and why melanocortin-based drugs might affect blood pressure.

Published in 2007, so more recent findings may have expanded on these observations. All cardiovascular and renal data discussed is from animal models — clinical translation to human hypertension has not been established. The mechanism linking salt-sensitive hypertension to insulin resistance via melanocortins was not yet determined at the time of publication.